rheumatoid arthritis

3 Reasons to Expect Smooth Sailing for AbbVie's Mission-Critical Candidate
Yahoo/Motley Fool
Sun, 06/10/18 - 10:59 am
AbbVie
Huimra
Upadacitinib
rheumatoid arthritis
AbbVie to submit upadacitinib to FDA after 5th trial win
Fierce Pharma
Wed, 06/6/18 - 11:31 am
AbbVie
Upadacitinib
rheumatoid arthritis
FDA
JAK inhibitors
Eli Lilly’s Arthritis Drug Approved at Lower Dose with Boxed Warning
Xconomy
Fri, 06/1/18 - 10:36 pm
Eli Lilly
Incyte
FDA
rheumatoid arthritis
olumiant
baricitinib
Gilead and Alphabet's Verily to Collaborate on Research in Immunological and Molecular Drivers of Inflammatory Diseases
CP Wire
Mon, 04/30/18 - 09:08 pm
Gilead Sciences
Verily
Immunoscape
lupus
rheumatoid arthritis
inflammatory bowel disease
AbbVie's Upadacitinib Meets Primary and Key Efficacy Endpoints in Phase 2b/3 Rheumatoid Arthritis Study
CP Wire
Wed, 04/25/18 - 11:16 am
AbbVie
rheumatoid arthritis
Upadacitinib
clinical trials
FDA Panel Splits on Lilly Arthritis Drug, Backs Lower of Two Doses
Xconomy
Mon, 04/23/18 - 11:15 pm
Eli Lilly
FDA
advisory panels
rheumatoid arthritis
baricitinib
Incyte
Big Week Ahead for Eli Lilly: Here's What to Look For
Motley Fool
Sun, 04/22/18 - 12:12 pm
Eli Lilly
earnings
FDA
Incyte
olumiant
rheumatoid arthritis
3 Biotech Stocks With Major Catalysts Incoming
Motley Fool
Fri, 04/20/18 - 12:45 pm
Incyte
TG Therapeutics
Cara Therapeutics
CR845
opioids
ublituximab
leukemia
olumiant
rheumatoid arthritis
Safety Concerns Linger for Lilly’s Arthritis Drug as FDA Panel Looms
Xconomy
Fri, 04/20/18 - 09:30 am
Eli Lilly
baricitinib
olumiant
rheumatoid arthritis
With study success, AbbVie's arthritis hopeful looks to be a safer bet
Biopharma Dive
Wed, 04/11/18 - 09:18 am
AbbVie
rheumatoid arthritis
Upadacitinib
Humira
clinical trials
Hydrogel delivery enables long-lasting, ‘flare-responsive’ arthritis treatment
Fierce Biotech
Sat, 04/7/18 - 09:23 am
Alivio Therapeutics
hydrogels
rheumatoid arthritis
Positive momentum for biotech Incyte
GoinPharma
Thu, 03/29/18 - 09:30 pm
Inctye
olumiant
baricitinib
rheumatoid arthritis
This 3D-printed device analyzes tissue cells from rheumatoid arthritis
Medical Design and Outsourcing
Sun, 03/11/18 - 11:48 am
3D printing
rheumatoid arthritis
diagnostics
$690M deal in peril after Lilly ends mid-stage studies
Biopharma Dive
Wed, 02/21/18 - 09:43 am
Eli Lilly
clinical trials
rheumatoid arthritis
Btk inhibitors
Hanmi Pharmaceutical
LY3337641/HM71224
Eli Lilly shutters a failed PhII for rheumatoid arthritis, clouding $690M Hanmi pact
Endpoints
Mon, 02/19/18 - 11:46 am
Eli Lilly
rheumatoid arthritis
Hanmi Pharmaceutical
clinical trials
Why AbbVie's Upadacitinib Keeps Posting Strong Data for Rheumatoid Arthritis
Market Realist
Mon, 01/8/18 - 09:42 am
AbbVie
Upadacitinib
rheumatoid arthritis
Another death mars AbbVie’s latest batch of promising data for its star rheumatoid arthritis drug
BioPharma Dive
Wed, 12/20/17 - 11:42 am
AbbVie
rheumatoid arthritis
Upadacitinib
ABT-494
Pfizer's second biosimilar of J&J's Remicade wins U.S. FDA approval
Yahoo/Reuters
Thu, 12/14/17 - 09:18 am
Pfizer
biosimilars
JNJ
Remicade
Ifixi
rheumatoid arthritis
Crohn's Disease
Amgen launches Enbrel Mini single-dose cartridges with reusable auto-injector
Drug Delivery Business News
Sat, 11/18/17 - 03:34 pm
Amgen
Enbrel Mini
auto-injectors
rheumatoid arthritis
Janssen drops U.S. lawsuit against Samsung Bioepis' Remicade copy
Yahoo/Reuters
Tue, 11/14/17 - 07:57 am
Janssen
Samsung Bioepis
Remicade
biosimilars
rheumatoid arthritis

Pages